Optimum Investment Advisors Charles River Laboratories International, Inc. Transaction History

Optimum Investment Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 08, 2022	SELL	$255.51 - $362.11 $134,142 - $190,107	-525 Closed	0 $0
Q4 2021 Mar 17, 2022	SELL	$351.38 - $448.68 $43,922 - $56,085	-125 Reduced 19.23%	525 $198,000
Q3 2021 Oct 22, 2021	SELL	$372.64 - $458.3 $65,212 - $80,202	-175 Reduced 21.21%	650 $268,000
Q4 2020 Jan 21, 2021	SELL	$222.0 - $252.62 $11,100 - $12,631	-50 Reduced 5.71%	825 $206,000
Q3 2020 Oct 06, 2020	BUY	$175.56 - $226.45 $153,615 - $198,143	875 New	875 $198,000

698

52.3M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $10.1B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Optimum Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Optimum Investment Advisors with notifications on news.